To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CXADRTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
347 supporting clones for gene CXADR back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX418162 brain, fetal brain .a 1 to 1103 1 to 1099   tiling clone,   1101/1103
(99 %)
18 diff
(98.4 %id)
CV570985 cornea, eye .a 75 to 701 1 to 627       627/627
(100 %)
0 diff
(100 %id)
DA180286 amygdala .a 134 to 690 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BM547121 brain, hippocampus .a 166 to 1135 15 to 988       974/1022
(95 %)
20 diff
(98.1 %id)
BG718557 testis .a 172 to 891 1 to 724       724/727
(99 %)
19 diff
(97.4 %id)
NM_001338.3   .a 181 to 2650 1 to 2470   RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2470/2470
(100 %)
0 diff
(100 %id)
DA515267 brain .a 184 to 724 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
BM804211 duodenal adenocarcinoma, cell line, small intestine .a 185 to 829 1 to 647       647/1240
(52 %)
18 diff
(98.6 %id)
DA745655   .a 186 to 762 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA776834 brain .a 186 to 760 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA769386 brain .a 189 to 773 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DA505333 brain .a 191 to 752 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
AU098965   .a 191 to 490 1 to 300       300/300
(100 %)
8 diff
(97.4 %id)
DA687642   .a 191 to 728 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA793016 brain .a 191 to 690 2 to 502   capped   501/501
(100 %)
3 diff
(99.5 %id)
BP315838 mammary gland .a 191 to 769 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
DA386276 thalamus .a 192 to 780 2 to 590   capped   589/590
(99 %)
1 diff
(99.9 %id)
DA522416 brain .a 192 to 747 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA742427   .a 192 to 752 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA752738   .a 192 to 752 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA783420 brain .a 192 to 766 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BC003684 Cervix, carcinoma .a 198 to 2650 1 to 2453   available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2453/2453
(100 %)
1 diff
(100.0 %id)
AU076628   .a 204 to 341 1 to 138       138/145
(95 %)
10 diff
(93.2 %id)
DA513284 brain .a 206 to 776 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BP239273 Liver .a 211 to 773 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
AK313526   .a 212 to 1396 1 to 1185   tiling clone,   1185/1185
(100 %)
0 diff
(100 %id)
AU103951   .a 212 to 261 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
BP238588 Liver .a 212 to 789 1 to 579       579/610
(94 %)
22 diff
(96.4 %id)
AU103952   .a 212 to 261 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
BP239172 Liver .a 212 to 825 1 to 614       614/614
(100 %)
20 diff
(96.8 %id)
BP241115 Liver .a 212 to 766 1 to 555       555/555
(100 %)
4 diff
(99.3 %id)
BP242100 Liver .a 212 to 796 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
BP242838 Liver .a 212 to 792 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
AU103960   .a 212 to 260 1 to 50       50/50
(100 %)
2 diff
(96.0 %id)
BP243151 Liver .a 212 to 792 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP243944 Liver .a 212 to 783 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
BJ991508 hepatoblastoma .a 212 to 793 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP280595   .a 212 to 833 1 to 618       618/618
(100 %)
13 diff
(97.9 %id)
BM750447 Ascites, stomach .a 212 to 768 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
DA055250 cerebellum .a 213 to 766 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA435185 tongue, tumor tissue .a 213 to 767 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA452983 tongue, tumor tissue .a 213 to 779 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA511451 brain .a 213 to 767 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA519411 brain .a 213 to 737 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DA523281 brain .a 213 to 769 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA528533 brain .a 213 to 805 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA532695 brain .a 213 to 690 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA593528 lung .a 213 to 791 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA719312   .a 213 to 724 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
DA719848   .a 213 to 785 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AU131437   .a 213 to 1047 2 to 840   capped   839/878
(95 %)
14 diff
(98.5 %id)
DA739012   .a 213 to 754 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DA740925   .a 213 to 717 2 to 507   capped   506/506
(100 %)
1 diff
(99.9 %id)
DA747711   .a 213 to 773 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA753372   .a 213 to 718 2 to 507   capped   506/508
(99 %)
3 diff
(99.5 %id)
DA775567 brain .a 213 to 801 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA778139 brain .a 213 to 635 2 to 424   capped   423/423
(100 %)
0 diff
(100 %id)
DA789998 brain .a 213 to 797 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
DB037674 testis .a 213 to 766 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB197348 trachea .a 213 to 770 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB203376 trachea .a 213 to 799 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA309538 hippocampus .a 215 to 813 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
BE545085 cervical carcinoma cell line, cervix .a 219 to 971 1 to 748       748/753
(99 %)
22 diff
(97.1 %id)
DA704108   .a 219 to 729 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
DA710528   .a 221 to 772 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
AL521066 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 223 to 1135 1 to 913       913/913
(100 %)
0 diff
(100 %id)
BI823597 pooled brain, lung, testis .a 223 to 943 1 to 722       722/885
(81 %)
13 diff
(98.6 %id)
TI_57202598   .a 223 to 943 86 to 807       722/970
(74 %)
19 diff
(98.1 %id)
BC010536 Cervix, carcinoma .a 224 to 2650 1 to 2427   available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2427/2427
(100 %)
1 diff
(100.0 %id)
CV573308 cornea, eye .a 224 to 841 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
DN990602 brain, whole brain .a 227 to 911 1 to 685       685/685
(100 %)
4 diff
(99.5 %id)
DA753806   .a 238 to 724 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
DA688702   .a 243 to 646 2 to 405   capped   404/404
(100 %)
0 diff
(100 %id)
BE543957 cervical carcinoma cell line, cervix .a 245 to 858 1 to 632       632/632
(100 %)
31 diff
(95.1 %id)
Y07593   .a 246 to 2651 7 to 2412   tiling clone, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 2406/2413
(99 %)
2 diff
(100.0 %id)
CV569974 cornea, eye .a 248 to 882 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BP259806 heart .a 262 to 811 1 to 550       550/550
(100 %)
7 diff
(98.8 %id)
AU103955.
matches multiple genes
  .a 264 to 313 1 to 50     also hits gene LOC100287357 50/50
(100 %)
2 diff
(96.0 %id)
BP240032 Liver .a 264 to 828 1 to 565       565/565
(100 %)
6 diff
(99.0 %id)
DA640694 Liver .a 264 to 823 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
AU103957   .a 265 to 314 1 to 50       50/50
(100 %)
2 diff
(96.0 %id)
BP241054 Liver .a 265 to 841 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
DA687137   .a 266 to 814 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA270430 caudate nucleus .a 272 to 845 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB196109 trachea .a 272 to 805 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
CD708568 normal nasopharynx .a 275 to 663 10 to 398       389/398
(97 %)
9 diff
(97.8 %id)
CF597534 ovary .a 278 to 875 1 to 600       600/755
(79 %)
12 diff
(98.5 %id)
AU103949   .a 282 to 331 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP237540 Liver .a 282 to 904 1 to 623       623/624
(99 %)
3 diff
(99.6 %id)
BP342597 stomach mucosa .a 282 to 851 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
DB015894 esophageal, tumor tissue .a 288 to 592 2 to 307   capped   306/306
(100 %)
1 diff
(99.7 %id)
CV572135 cornea, eye .a 290 to 932 1 to 643       643/643
(100 %)
0 diff
(100 %id)
TI_1948076232   .a 292 to 1397 132 to 1240   fully sequenced,   1109/1240
(89 %)
56 diff
(95.5 %id)
TI_1948076411   .a 292 to 1391 132 to 1224   fully sequenced,   1093/1224
(89 %)
47 diff
(96.2 %id)
TI_1948076592   .a 292 to 1398 127 to 1227   fully sequenced,   1101/1227
(89 %)
53 diff
(95.7 %id)
TI_1948076771   .a 292 to 900 128 to 736   fully sequenced, AAA   609/736
(82 %)
7 diff
(99.1 %id)
BT019876   .a 299 to 1396 1 to 1098       1098/1098
(100 %)
0 diff
(100 %id)
CV023420 mixed .a 299 to 934 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
TI_57218475   .a 299 to 1201 34 to 956       923/957
(96 %)
43 diff
(95.6 %id)
U90716   .a 299 to 2650 1 to 2354       2354/2354
(100 %)
9 diff
(99.7 %id)
BI754365 brain .a 301 to 1201 1 to 921       921/922
(99 %)
37 diff
(96.0 %id)
AL709335 human skeletal muscle .a 339 to 862 1 to 525       525/531
(98 %)
2 diff
(99.7 %id)
N31467 melanocyte .a 356 to 723 1 to 375       375/383
(97 %)
14 diff
(96.4 %id)
AL534436 brain, fetal brain .a 383 to 1287 1 to 904       904/924
(97 %)
35 diff
(96.3 %id)
BU192852 eye, retinoblastoma .a 770 to 1685 1 to 920       920/920
(100 %)
10 diff
(99.0 %id)
TI_1948076233   .a 839 to 1395 681 to 125   fully sequenced,   557/681
(81 %)
0 diff
(100 %id)
TI_1948076412   .a 839 to 1395 683 to 127   fully sequenced,   557/683
(81 %)
0 diff
(100 %id)
TI_1948076593   .a 839 to 1395 682 to 126   fully sequenced,   557/682
(81 %)
0 diff
(100 %id)
TI_1948076772   .a 839 to 1395 682 to 126   fully sequenced,   557/682
(81 %)
0 diff
(100 %id)
BG570867 placenta .a 859 to 1690 1 to 823       823/825
(99 %)
17 diff
(98.0 %id)
BP293870 lung .a 873 to 1453 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CD238805 Pituitary .a 879 to 1607 1 to 729       729/729
(100 %)
3 diff
(99.6 %id)
AA089566   .a 1132 to 1437 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
BM839359 Ascites, stomach .a 1136 to 1624 1 to 489       489/489
(100 %)
1 diff
(99.8 %id)
F05145 brain, total brain .a 1137 to 1417 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
Z44690 brain, total brain .a 1137 to 1487 1 to 350       350/350
(100 %)
1 diff
(99.8 %id)
BX480412   .a 1193 to 1753 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
DB450066 testis .a 1219 to 1685 1 to 461       461/463
(99 %)
14 diff
(97.0 %id)
BU854543 testis .a 1279 to 1942 1 to 672       672/851
(78 %)
19 diff
(97.8 %id)
AI557255 Prostate .a 1318 to 1977 1 to 665     Submitted on the opposite strand 665/881
(75 %)
18 diff
(98.0 %id)
CN369265 embryonic stem cells, DMSO-treated H9 cellline .a 1380 to 1626 1 to 248       248/248
(100 %)
1 diff
(99.6 %id)
AA847725 ovary .a 1389 to 1494 1 to 106       106/128
(82 %)
1 diff
(99.3 %id)
BM542234 melanotic melanoma, skin .a 1498 to 2339 27 to 875       849/1002
(84 %)
15 diff
(98.6 %id)
CN369263 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1525 to 2077 3 to 555       553/555
(99 %)
6 diff
(99.0 %id)
CB130008 Liver .a 1560 to 2137 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BX418161 brain, fetal brain .a 1577 to 2621 1042 to 1       1042/1097
(94 %)
22 diff
(98.0 %id)
BF241979 bone marrow, from acute myelogenous leukemia .a 1628 to 2338 1 to 710       710/846
(83 %)
28 diff
(96.7 %id)
AL521065 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1644 to 2635 994 to 1       994/994
(100 %)
16 diff
(98.4 %id)
BX418160 brain, fetal brain .a 1666 to 2600 933 to 1       933/933
(100 %)
24 diff
(97.5 %id)
AL534435 brain, fetal brain .a 1676 to 2596 917 to 6       912/970
(94 %)
0 diff
(100 %id)
AA102279 colon, tumor .a 1715 to 2117 1 to 404     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 404/404
(100 %)
2 diff
(99.6 %id)
DA806366 brain .a 1718 to 2292 2 to 578   capped   577/577
(100 %)
4 diff
(99.4 %id)
BF832372 head_neck .a 1732 to 2137 1 to 406       406/406
(100 %)
5 diff
(98.8 %id)
BG989683 head_neck .a 1733 to 2226 1 to 494       494/494
(100 %)
13 diff
(97.4 %id)
BF834286 head_neck .a 1777 to 2261 42 to 529       488/529
(92 %)
10 diff
(98.2 %id)
BF834964 head_neck .a 1778 to 2069 36 to 327       292/327
(89 %)
6 diff
(98.2 %id)
AU123387   .a 1857 to 2501 2 to 646   capped   645/654
(98 %)
4 diff
(99.4 %id)
CV573027 cornea, eye .a 1939 to 2513 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BG260063 bladder, transitional cell papilloma, cell line .a 1957 to 2659 1 to 714       714/760
(93 %)
21 diff
(97.3 %id)
BI489768 pooled brain, lung, testis .a 1968 to 2680 1 to 704       704/713
(98 %)
12 diff
(98.4 %id)
TI_43961679   .a 1970 to 2680 66 to 767       702/1019
(68 %)
11 diff
(99.0 %id)
DB088334 testis .a 2000 to 2547 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BF209372 bone marrow, from chronic myelogenous leukemia .a 2029 to 2254 328 to 555       518/555
(93 %)
46 diff
(91.8 %id)
BP223598 colon mucosa .a 2052 to 2389 1 to 338       338/343
(98 %)
2 diff
(99.5 %id)
Z47309   .a 2063 to 2315 1 to 256       256/256
(100 %)
4 diff
(98.5 %id)
AW604761 colon .a 2070 to 2729 25 to 677   tiling clone,   653/682
(95 %)
16 diff
(97.7 %id)
BG287694 bladder, transitional cell papilloma, cell line .a 2073 to 2631 1 to 561       561/767
(73 %)
4 diff
(99.5 %id)
AI923746 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2090 to 2658 570 to 1       570/570
(100 %)
2 diff
(99.7 %id)
BJ991509 hepatoblastoma .a 2091 to 2630 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BF056469 pooled germ cell tumors .a 2097 to 2655 559 to 1       559/559
(100 %)
1 diff
(99.9 %id)
AU153169   .a 2104 to 2650 543 to 1       543/549
(98 %)
12 diff
(97.9 %id)
AW190120 adenocarcinoma, Pancreas .a 2109 to 2652 545 to 1       545/545
(100 %)
1 diff
(99.9 %id)
AI718484 colon .a 2119 to 2650 532 to 1       532/532
(100 %)
0 diff
(100 %id)
BF476200 Kidney .a 2119 to 2652 534 to 1       534/534
(100 %)
0 diff
(100 %id)
DA768059 brain .a 2123 to 2698 2 to 577   tiling clone, capped   576/576
(100 %)
2 diff
(99.7 %id)
BP424959 small intestine .a 2145 to 2652 1 to 509     Submitted on the opposite strand 509/509
(100 %)
1 diff
(99.9 %id)
AI917483 pooled germ cell tumors .a 2145 to 2652 508 to 1       508/508
(100 %)
1 diff
(99.9 %id)
AA977172 pooled germ cell tumors .a 2153 to 2650 498 to 1       498/498
(100 %)
0 diff
(100 %id)
AI917487 pooled germ cell tumors .a 2154 to 2650 497 to 1       497/497
(100 %)
1 diff
(99.8 %id)
AI218013 pooled .a 2162 to 2649 488 to 1       488/488
(100 %)
1 diff
(99.8 %id)
BF062895 colon, colon tumor, RER+ .a 2173 to 2651 479 to 1       479/479
(100 %)
0 diff
(100 %id)
BE503229 pooled germ cell tumors .a 2185 to 2649 478 to 14   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 465/465
(100 %)
0 diff
(100 %id)
AI024837   .a 2186 to 2653 468 to 1       468/468
(100 %)
3 diff
(99.4 %id)
AI990180 pooled germ cell tumors .a 2205 to 2652 448 to 1       448/605
(74 %)
0 diff
(100 %id)
AI394410 pooled .a 2215 to 2659 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI290221 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2217 to 2650 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AI369746 anaplastic oligodendroglioma, brain .a 2217 to 2650 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AA128199 colon, tumor .a 2219 to 2302 1 to 84       84/84
(100 %)
0 diff
(100 %id)
AI042282 senescent fibroblast .a 2219 to 2655 437 to 1       437/437
(100 %)
3 diff
(99.4 %id)
AI378896 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2219 to 2662 444 to 1       444/444
(100 %)
1 diff
(99.8 %id)
AW589681 pooled germ cell tumors .a 2229 to 2650 435 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 423/423
(100 %)
1 diff
(99.8 %id)
AI066454 colon, colon tumor .a 2239 to 2651 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AI922147 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2240 to 2675 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AI275711 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2242 to 2651 414 to 1       414/414
(100 %)
4 diff
(99.1 %id)
AI569732 anaplastic oligodendroglioma, brain .a 2248 to 2651 404 to 1       404/404
(100 %)
1 diff
(99.8 %id)
AW265156 endometrioid ovarian metastasis, ovary .a 2269 to 2646 378 to 1       378/378
(100 %)
0 diff
(100 %id)
AA676233 liver and spleen .a 2274 to 2543 270 to 1       270/270
(100 %)
0 diff
(100 %id)
AA954469 pooled .a 2280 to 2651 372 to 1       372/372
(100 %)
0 diff
(100 %id)
AA857028 pharynx, squamous cell carcinoma .a 2301 to 2654 354 to 1       354/354
(100 %)
1 diff
(99.8 %id)
AI249114 liver and spleen .a 2307 to 2662 357 to 2       356/357
(99 %)
0 diff
(100 %id)
AI498465 Kidney .a 2308 to 2653 346 to 1       346/346
(100 %)
1 diff
(99.8 %id)
AA583093 germ cell tumor .a 2325 to 2651 327 to 1       327/397
(82 %)
0 diff
(100 %id)
N25352 melanocyte .a 2332 to 2642 319 to 9       311/319
(97 %)
0 diff
(100 %id)
BI490703 pooled brain, lung, testis .a 2332 to 2572 245 to 1       535/643
(83 %)
58 diff
(91.0 %id)
TI_43961531   .a 2332 to 2572 245 to 1       535/993
(53 %)
58 diff
(94.2 %id)
AI538104 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2336 to 2652 317 to 1       317/317
(100 %)
0 diff
(100 %id)
AA666170   .a 2342 to 2602 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AA644305 lung, lung carcinoma .a 2354 to 2635 282 to 1       282/282
(100 %)
1 diff
(99.7 %id)
Z47308   .a 2356 to 2628 1 to 282       282/282
(100 %)
25 diff
(91.2 %id)
AA100291 colon, tumor .a 2400 to 2650 266 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 251/251
(100 %)
0 diff
(100 %id)
Z40534 brain, total brain .a 2409 to 2645 242 to 6       237/242
(97 %)
0 diff
(100 %id)
N52169 multiple sclerosis lesions .a 2414 to 2670 256 to 1       256/258
(99 %)
2 diff
(99.3 %id)
BP385708 pancreatic islet .a 2441 to 2659 1 to 221     Submitted on the opposite strand 221/221
(100 %)
3 diff
(98.7 %id)
AA128200 colon, tumor .a 2552 to 2659 110 to 3       108/110
(98 %)
0 diff
(100 %id)
GD138521   .a 2571 to 2649 1 to 79   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 79/79
(100 %)
2 diff
(97.5 %id)
AF124598 Liver .b 1 to 1033 1 to 1033   tiling clone,   1033/1033
(100 %)
2 diff
(99.9 %id)
DA746345   .b 86 to 651 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CR617256 HeLa cells Cot 25-normalized .b 126 to 1445 1 to 1320   tiling clone,   1320/1320
(100 %)
0 diff
(100 %id)
AL555497 placenta .b 126 to 864 1 to 739   fully sequenced,   739/739
(100 %)
0 diff
(100 %id)
BP343393 stomach mucosa .b 147 to 729 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DA514939 brain .b 164 to 692 2 to 532   capped   531/546
(97 %)
3 diff
(99.5 %id)
CN369264 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 264 to 778 1 to 516       516/516
(100 %)
3 diff
(99.5 %id)
CV574192 cornea, eye .b 338 to 970 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
AA249468   .b 359 to 698 1 to 337       337/346
(97 %)
10 diff
(97.2 %id)
CB132874 Liver .b 410 to 778 166 to 534       369/534
(69 %)
6 diff
(98.9 %id)
BP221156 colon .b 452 to 1021 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
CN274390 embryonic stem cells, DMSO-treated H9 cellline .b 540 to 684 1 to 145       145/145
(100 %)
0 diff
(100 %id)
AL577981 placenta .b 803 to 1445 644 to 1   fully sequenced,   644/644
(100 %)
1 diff
(99.9 %id)
BM703645 eye, human retina .b 1317 to 1775 1 to 459   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
AW243562 pooled germ cell tumors .b 1330 to 1776 449 to 3   tiling clone,   447/449
(99 %)
0 diff
(100 %id)
DB562151 hypothalamus .b 1520 to 1962 443 to 1       443/443
(100 %)
13 diff
(97.1 %id)
AA176808   .b 1520 to 1858 1 to 340   fully sequenced,   340/340
(100 %)
0 diff
(100 %id)
BP395920 pancreatic islet .b 1521 to 1952 435 to 1       435/439
(99 %)
6 diff
(98.7 %id)
DB543690.
matches multiple genes
hippocampus .b 1523 to 1969 447 to 1     also hits gene BTG3 447/447
(100 %)
0 diff
(100 %id)
BP393535 pancreatic islet .b 1523 to 2021 499 to 1       499/499
(100 %)
8 diff
(98.4 %id)
EC472907 Prostate .b 1526 to 1629 12 to 114       103/114
(90 %)
6 diff
(94.8 %id)
CB122603 Liver .b 1544 to 2154 1 to 610   tiling clone,   610/610
(100 %)
1 diff
(99.9 %id)
BP425353 small intestine .b 1581 to 2123 544 to 1       544/544
(100 %)
4 diff
(99.3 %id)
BE844094 testis_normal .b 1756 to 2115 1 to 360       360/360
(100 %)
6 diff
(98.4 %id)
AA176652   .b 1828 to 2181 354 to 1   fully sequenced,   354/354
(100 %)
0 diff
(100 %id)
AW886625 ovary .b 1838 to 2124 1 to 286       286/294
(97 %)
5 diff
(98.3 %id)
AW590069 pooled germ cell tumors .b 1843 to 2438 596 to 1   tiling clone,   596/599
(99 %)
0 diff
(100 %id)
BF057127 pooled germ cell tumors .b 1944 to 2438 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
FN172952 breast carcinoma .b 1953 to 2047 1 to 95       95/98
(96 %)
1 diff
(99.0 %id)
FN175401 breast carcinoma .b 1953 to 2038 1 to 84       84/92
(91 %)
5 diff
(94.6 %id)
AW594600 pooled germ cell tumors .b 1953 to 2438 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
AI214281 pooled germ cell tumors .b 1961 to 2438 478 to 1       478/478
(100 %)
0 diff
(100 %id)
BF062255 pooled germ cell tumors .b 1962 to 2438 477 to 1       477/477
(100 %)
4 diff
(99.2 %id)
BF224015 pooled germ cell tumors .b 1962 to 2438 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
BI757097 brain .b 2158 to 2889 1 to 739       739/829
(89 %)
17 diff
(98.0 %id)
TI_57221645   .b 2158 to 2963 72 to 891       820/900
(91 %)
6 diff
(99.4 %id)
BF478250 pooled germ cell tumors .b 2185 to 2438 256 to 1       256/266
(96 %)
6 diff
(97.8 %id)
AW778898 colon, moderately-differentiated adenocarcinoma .b 2350 to 2869 520 to 1   tiling clone,   520/520
(100 %)
0 diff
(100 %id)
BF878621 lung_tumor .b 2378 to 2586 212 to 4     Submitted on the opposite strand 209/212
(98 %)
0 diff
(100 %id)
AW779053 colon, moderately-differentiated adenocarcinoma .b 2388 to 2869 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AI955070 pooled germ cell tumors .b 2411 to 2880 470 to 1       470/470
(100 %)
6 diff
(98.8 %id)
AI336853 pooled germ cell tumors .b 2418 to 2869 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI686754 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2447 to 2870 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AA780619   .b 2480 to 2869 388 to 1       388/388
(100 %)
2 diff
(99.5 %id)
AW628404 2 pooled high-grade transitional celltumors, genitourinary tract .b 2489 to 2873 385 to 1       385/385
(100 %)
0 diff
(100 %id)
BM837830 Ascites, stomach .b 2641 to 3319 1 to 681   tiling clone,   681/681
(100 %)
2 diff
(99.8 %id)
AV688890 hepatocellular carcinoma .b 2822 to 3214 1 to 391   tiling clone,   391/403
(97 %)
2 diff
(99.6 %id)
GU474812   .c 1 to 975 1 to 975 exact tiling clone,   975/975
(100 %)
1 diff
(99.9 %id)
BX376692 Neuroblastoma Cot 50-normalized .d 1 to 1075 5 to 1071 exact tiling clone,   1071/1071
(100 %)
13 diff
(98.8 %id)
CX758702 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 6 to 737 1 to 724     Submitted on the opposite strand 724/855
(84 %)
14 diff
(98.4 %id)
AL514786 neuroblastoma, placenta .d 7 to 898 1 to 890 N96Y Y147X tiling clone,   890/890
(100 %)
7 diff
(99.3 %id)
AY072912   .d 81 to 839 1 to 759 exact     759/759
(100 %)
1 diff
(99.9 %id)
W39780 Pancreas, pancreatic islet .d 268 to 651 1 to 386       386/391
(98 %)
4 diff
(99.0 %id)
AA299472 uterus .d 474 to 796 1 to 329       329/338
(97 %)
11 diff
(96.8 %id)
AL514785 neuroblastoma, placenta .d 1332 to 2196 862 to 1   tiling clone,   862/862
(100 %)
0 diff
(100 %id)
BX351256 Neuroblastoma Cot 50-normalized .d 1454 to 2166 747 to 27   tiling clone,   721/945
(76 %)
0 diff
(100 %id)
W45313 Pancreas, pancreatic islet .d 1881 to 2200 321 to 3   tiling clone,   319/326
(97 %)
0 diff
(100 %id)
AY072911   .e 1 to 603 1 to 603   tiling clone,   603/603
(100 %)
1 diff
(99.9 %id)
DB522390.
matches multiple genes
testis .e 413 to 710 159 to 456   tiling clone, Submitted on the opposite strand, also hits gene FLVCR2andTTLL5andC14orf179 298/460
(64 %)
7 diff
(98.5 %id)
BP372920 umbilical cord .f 1 to 572 1 to 572 F131X tiling clone,   572/572
(100 %)
0 diff
(100 %id)
DA412244 thalamus .g 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
AY072910   .h 1 to 270 1 to 270 exact tiling clone,   270/270
(100 %)
1 diff
(99.7 %id)
AL049332 brain .i-u 1 to 3745 1 to 3750   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 3750/3750
(100 %)
5 diff
(99.9 %id)
DB511737 testis .i-u 200 to 408 317 to 108       210/317
(66 %)
0 diff
(100 %id)
AW993925 breast_normal .i-u 1173 to 1826 22 to 674   tiling clone,   653/679
(96 %)
12 diff
(98.3 %id)
DA720100   .j-u 1 to 568 2 to 571 C29X C30L V31C I32D K33Q ... tiling clone, capped   570/570
(100 %)
3 diff
(99.5 %id)
BG496605 lung, mucoepidermoid carcinoma .j-u 47 to 883 1 to 846 exact tiling clone,   846/846
(100 %)
37 diff
(95.7 %id)
CN257051 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j-u 145 to 902 1 to 759   tiling clone,   759/759
(100 %)
4 diff
(99.5 %id)
N46621 multiple sclerosis lesions .j-u 277 to 493 1 to 217       217/217
(100 %)
2 diff
(99.1 %id)
CU451696 epidermis .j-u 372 to 803 16 to 447       432/447
(96 %)
6 diff
(98.7 %id)
CU452582 epidermis .j-u 380 to 847 25 to 492       468/545
(85 %)
4 diff
(99.3 %id)
CU453934 epidermis .j-u 380 to 817 25 to 462       438/462
(94 %)
6 diff
(98.8 %id)
BF223203 pooled germ cell tumors .j-u 483 to 1063 579 to 1       579/579
(100 %)
3 diff
(99.5 %id)
BX479910   .j-u 505 to 1138 1 to 634       634/634
(100 %)
4 diff
(99.4 %id)
DA732459   .j-u 602 to 1335 2 to 741   capped   740/758
(97 %)
18 diff
(97.7 %id)
AI921735 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 607 to 1060 470 to 16   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 455/455
(100 %)
4 diff
(99.2 %id)
AI638487 pooled germ cell tumors .j-u 622 to 1063 448 to 11   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 438/438
(100 %)
6 diff
(98.7 %id)
AI685529 Prostate .j-u 647 to 1064 416 to 1       416/416
(100 %)
8 diff
(98.1 %id)
AI656376 pooled germ cell tumors .j-u 671 to 1063 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
AA628336   .j-u 682 to 1063 382 to 1   tiling clone,   382/382
(100 %)
1 diff
(99.8 %id)
BF431278 Kidney .j-u 702 to 1065 364 to 1       364/364
(100 %)
3 diff
(99.2 %id)
N34895 multiple sclerosis lesions .j-u 797 to 1082 288 to 2       287/290
(98 %)
0 diff
(100 %id)
DA708946   .j-u 921 to 1470 2 to 553   tiling clone, capped   552/552
(100 %)
3 diff
(99.5 %id)
BG427243 Kidney .j-u 1062 to 1114 679 to 731       689/921
(74 %)
32 diff
(96.6 %id)
DA715930   .j-u 1150 to 1636 2 to 492   capped   491/491
(100 %)
3 diff
(99.4 %id)
AA291523 ovarian tumor, ovary .j-u 1181 to 1441 1 to 261     Submitted on the opposite strand 261/261
(100 %)
0 diff
(100 %id)
DA733721   .j-u 1284 to 1976 2 to 693   capped   692/696
(99 %)
12 diff
(98.3 %id)
BJ991126 hepatoblastoma .j-u 1291 to 1873 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BX478135   .j-u 1428 to 1934 18 to 524   tiling clone,   507/524
(96 %)
6 diff
(98.9 %id)
CX871184 embryonic stem .j-u 1432 to 1974 11 to 555       545/555
(98 %)
6 diff
(99.0 %id)
BX486979   .j-u 1434 to 1908 27 to 500       474/500
(94 %)
7 diff
(98.6 %id)
CR603583 fetal brain .j-u 1499 to 3125 1 to 1627       1627/1627
(100 %)
0 diff
(100 %id)
AL538117 brain, fetal brain .j-u 1499 to 2617 1 to 1107       1107/1107
(100 %)
27 diff
(97.6 %id)
CR601061 fetal brain .j-u 1609 to 3401 1 to 1793   tiling clone,   1793/1793
(100 %)
0 diff
(100 %id)
BX440872 brain, fetal brain .j-u 1609 to 2649 1 to 1030   fully sequenced,   1030/1030
(100 %)
22 diff
(97.9 %id)
F07030 brain, total brain .j-u 1768 to 1987 1 to 220       220/220
(100 %)
0 diff
(100 %id)
CX786399 human embryonic stem cells .j-u 1820 to 2572 1 to 753       753/753
(100 %)
0 diff
(100 %id)
EL955603 eyeball .j-u 1826 to 2379 1 to 555       555/555
(100 %)
9 diff
(98.4 %id)
AA324208 brain .j-u 1829 to 2250 1 to 419       419/419
(100 %)
3 diff
(99.3 %id)
CN310849 embryonic stem cells, DMSO-treated H9 cellline .j-u 1935 to 2336 1 to 402       402/402
(100 %)
1 diff
(99.8 %id)
BG771295 adenocarcinoma, Prostate .j-u 1965 to 2752 1 to 798       798/802
(99 %)
31 diff
(96.2 %id)
AJ709505 heart .j-u 1997 to 2064 69 to 2     Submitted on the opposite strand 68/69
(98 %)
0 diff
(100 %id)
CD104120 Pooled-Skin .j-u 2002 to 2595 1 to 603       603/768
(78 %)
23 diff
(97.1 %id)
EX571726 intestinal (Lauren) gastric adenocarcinoma, stomach .j-u 2005 to 2475 1 to 471       471/573
(82 %)
10 diff
(98.3 %id)
BF037495 adenocarcinoma, ovary .j-u 2010 to 2635 1 to 616       616/659
(93 %)
18 diff
(97.3 %id)
BP392972 pancreatic islet .j-u 2041 to 2485 445 to 1       445/445
(100 %)
0 diff
(100 %id)
BE004331 breast_normal .j-u 2114 to 2488 384 to 9     Submitted on the opposite strand 376/384
(97 %)
0 diff
(100 %id)
BQ084356 stomach .j-u 2147 to 2563 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BX452195 brain, fetal brain .j-u 2226 to 3125 1 to 894       894/894
(100 %)
11 diff
(98.8 %id)
BE565825 bladder, carcinoma, cell line .j-u 2238 to 2871 1 to 635       635/635
(100 %)
31 diff
(95.2 %id)
BF916325 uterus_tumor .j-u 2254 to 2631 378 to 1     Submitted on the opposite strand 378/378
(100 %)
0 diff
(100 %id)
H89053 cochlea, ear .j-u 2344 to 2672 1 to 330       330/331
(99 %)
7 diff
(97.9 %id)
BG484885 lung .j-u 2344 to 3090 1 to 750       750/751
(99 %)
10 diff
(98.7 %id)
AL538116 brain, fetal brain .j-u 2409 to 3363 957 to 12       946/1042
(90 %)
13 diff
(98.8 %id)
BF678275 Prostate .j-u 2439 to 3139 1 to 684       684/854
(80 %)
19 diff
(97.8 %id)
CB987145 Pooled-Glandular .j-u 2474 to 3102 1 to 639       639/779
(82 %)
19 diff
(97.6 %id)
AW631062 2 pooled high-grade transitional celltumors, genitourinary tract .j-u 2475 to 2779 22 to 326       305/326
(93 %)
6 diff
(98.2 %id)
BF678792 Prostate .j-u 2494 to 3205 1 to 696       696/873
(79 %)
28 diff
(96.8 %id)
BM984113 lung, Primary Lung Epithelial Cells .j-u 2495 to 3189 1 to 695     Submitted on the opposite strand 695/695
(100 %)
2 diff
(99.8 %id)
TI_149283483   .j-u 2497 to 3210 61 to 774     Submitted on the opposite strand 714/774
(92 %)
6 diff
(99.3 %id)
AW205793   .j-u 2498 to 2771 1 to 273     Submitted on the opposite strand 273/273
(100 %)
6 diff
(97.9 %id)
TI_149276259   .j-u 2499 to 3403 986 to 84   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 903/995
(90 %)
33 diff
(96.7 %id)
TI_149276592   .j-u 2533 to 3406 947 to 82   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 866/874
(99 %)
19 diff
(97.9 %id)
AW021628 cochlea, ear .j-u 2599 to 2874 1 to 277   fully sequenced, Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 277/277
(100 %)
6 diff
(97.9 %id)
H89216 cochlea, ear .j-u 2617 to 2941 1 to 332       332/334
(99 %)
14 diff
(95.9 %id)
BX434861 brain, fetal brain .j-u 2619 to 3401 790 to 1   fully sequenced,   790/790
(100 %)
26 diff
(96.8 %id)
CB163072 Liver .j-u 2681 to 3309 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
AA133742 lung, lung carcinoma .j-u 2695 to 3016 1 to 325       325/329
(98 %)
7 diff
(97.9 %id)
BG403931 bladder, transitional cell papilloma, cell line .j-u 2722 to 3379 1 to 651       651/651
(100 %)
10 diff
(98.5 %id)
CA314161 Human Lung Epithelial cells, lung .j-u 2764 to 3403 659 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 641/641
(100 %)
4 diff
(99.4 %id)
BU677040 lung, Primary Lung Epithelial Cells .j-u 2772 to 3403 651 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 633/633
(100 %)
2 diff
(99.7 %id)
BU677281 lung, Primary Lung Epithelial Cells .j-u 2778 to 3406 647 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 629/629
(100 %)
1 diff
(99.9 %id)
AA244133   .j-u 2807 to 3274 1 to 468       468/468
(100 %)
5 diff
(99.0 %id)
AA173637   .j-u 2812 to 3199 1 to 392       392/446
(87 %)
6 diff
(98.7 %id)
BJ991127 hepatoblastoma .j-u 2839 to 3378 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
BI492573 cochlea, ear .j-u 2844 to 3403 577 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 560/560
(100 %)
1 diff
(99.9 %id)
BG260087 bladder, transitional cell papilloma, cell line .j-u 2853 to 3406 1 to 553   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 553/553
(100 %)
2 diff
(99.7 %id)
DB363954   .j-u 2854 to 3403 552 to 1       552/611
(90 %)
17 diff
(97.3 %id)
CX786081 human embryonic stem cells .j-u 2884 to 3404 550 to 30     Submitted on the opposite strand 521/550
(94 %)
0 diff
(100 %id)
TI_153990316   .j-u 2898 to 3406 614 to 105   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 510/635
(80 %)
8 diff
(98.8 %id)
DB365699   .j-u 2911 to 3405 494 to 1       494/495
(99 %)
2 diff
(99.6 %id)
BE550830 carcinoid, lung .j-u 2914 to 3405 489 to 1       489/489
(100 %)
6 diff
(98.8 %id)
AW102843 ovary, tumor, 5 pooled (see description) .j-u 2919 to 3405 488 to 2       487/488
(99 %)
0 diff
(100 %id)
AW078665 2 pooled high-grade transitional celltumors, genitourinary tract .j-u 2936 to 3404 470 to 1       470/470
(100 %)
3 diff
(99.4 %id)
AW206290   .j-u 2941 to 3406 484 to 18   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 467/467
(100 %)
8 diff
(98.3 %id)
AI914185 carcinoid, lung .j-u 2949 to 3406 459 to 4       456/464
(98 %)
0 diff
(100 %id)
BX097283 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 2955 to 3403 463 to 15   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 449/449
(100 %)
1 diff
(99.8 %id)
AI142558 brain, glioblastoma (pooled) .j-u 2973 to 3406 449 to 16   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 434/434
(100 %)
1 diff
(99.8 %id)
AI422307 brain, glioblastoma (pooled) .j-u 2973 to 3406 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
BF108536 carcinoid, lung .j-u 2973 to 3404 437 to 6       432/437
(98 %)
0 diff
(100 %id)
H89110 cochlea, ear .j-u 2974 to 3392 419 to 1       419/422
(99 %)
3 diff
(99.3 %id)
AI423282 brain, glioblastoma (pooled) .j-u 2976 to 3406 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AW316872 brain, three pooled meningiomas .j-u 2976 to 3406 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
DB515632 testis .j-u 2979 to 3401 1 to 423     Submitted on the opposite strand 423/428
(98 %)
5 diff
(98.9 %id)
BE856627 pooled .j-u 2996 to 3397 412 to 10       403/412
(97 %)
0 diff
(100 %id)
BF114696 pooled .j-u 2996 to 3406 412 to 2       411/412
(99 %)
0 diff
(100 %id)
AI610213 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 3017 to 3403 387 to 1       387/387
(100 %)
1 diff
(99.8 %id)
AW243788 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j-u 3020 to 3406 387 to 1       387/387
(100 %)
1 diff
(99.8 %id)
AI925064 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 3032 to 3403 391 to 20   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 372/372
(100 %)
1 diff
(99.8 %id)
ES274072 rectum .j-u 3035 to 3202 168 to 1     Submitted on the opposite strand 168/168
(100 %)
1 diff
(99.5 %id)
ES274082 rectum .j-u 3035 to 3202 168 to 1     Submitted on the opposite strand 168/168
(100 %)
0 diff
(100 %id)
AI472845 pooled .j-u 3043 to 3406 365 to 2       364/365
(99 %)
0 diff
(100 %id)
T33058 brain .j-u 3061 to 3403 343 to 1       343/350
(98 %)
1 diff
(99.8 %id)
AA622661 germ cell tumor .j-u 3067 to 3413 377 to 31   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 347/347
(100 %)
0 diff
(100 %id)
AI675478 Prostate .j-u 3068 to 3406 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
AA889562   .j-u 3075 to 3404 332 to 4       329/332
(99 %)
0 diff
(100 %id)
AI307117 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 3079 to 3403 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
AI658855 Prostate .j-u 3083 to 3401 324 to 6       319/324
(98 %)
0 diff
(100 %id)
BF221539 Prostate .j-u 3083 to 3406 326 to 3       324/326
(99 %)
0 diff
(100 %id)
AA548099 germ cell tumor .j-u 3084 to 3404 319 to 1       319/319
(100 %)
2 diff
(99.4 %id)
AA933888 2 pooled tumors (clear cell type), Kidney .j-u 3095 to 3403 323 to 15   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 309/309
(100 %)
1 diff
(99.7 %id)
Z40138 brain, total brain .j-u 3111 to 3406 296 to 1       296/296
(100 %)
2 diff
(99.4 %id)
AI471167 brain, glioblastoma (pooled) .j-u 3152 to 3406 255 to 1       255/255
(100 %)
1 diff
(99.7 %id)
AA425906 ovarian tumor, ovary .j-u 3168 to 3406 240 to 2       239/240
(99 %)
0 diff
(100 %id)
AI498294 Kidney .j-u 3217 to 3417 203 to 4   tiling clone,   200/209
(95 %)
0 diff
(100 %id)
AV752816 Pituitary .k-u 1 to 591 1 to 590 W12X W14R tiling clone,   590/728
(81 %)
12 diff
(98.4 %id)
DB234644 trachea .l-u 1 to 558 2 to 559 exact tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k-u, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI